reported a multifunctional drug delivery system comprising DOX and amorphous porous manganese phosphate (APMP) for combining chemotherapy with STING agonist‐based immunotherapy.[52a] This nanoplatform was fabricated via encapsulating DOX within APMP NPs, followed by a phospholipid (PL) coating to enhance stability during blood circulation and phospholipase‐mediated biodegradation at the tumor sites. This evidence concerns the gene STING1 and neoplasm.